Latest Anschutz Medical Campus Stories
Panel organized by 2040 Partners for Health will explore the impact of gun violence on neighborhoods in and around Denver. Denver, Colo. (PRWEB) February 08, 2013 A panel of community members from the Park Hill, Northeast Park Hill, Northwest Aurora, East Montclair and Stapleton neighborhoods will explore the effects that gun violence has had on their neighborhoods, and what their communities can do. “Like heart disease, diabetes, mental health issues and asthma, gun violence is a...
University of Colorado Cancer Center remains in distinguished company having received a prestigious designation from the National Cancer Institute (NCI). This is the fourth time the CU Cancer Center has been named a Comprehensive Cancer Center by the NCI – one of only 41 cancer centers in the United States to receive the designation. Aurora, Colo. (PRWEB) August 27, 2012 University of Colorado Cancer Center remains in distinguished company having received a prestigious designation from...
AURORA, Colo., March 14, 2012 /PRNewswire/ -- Following an extensive national search, Fitzsimons Redevelopment Authority (FRA) has named Steve VanNurden as its new President and Chief Executive Officer, beginning in late May. The announcement is made by John M. Shaw, Chair of the FRA Board of Directors, who said: "Steve, a seasoned leader in the life science/bioscience space, comes to us from Mayo Clinic in Rochester, Minnesota." The appointment of Mr. VanNurden is further evidence...
The Fitzsimons Redevelopment Authority (FRA) is expanding its Bioscience Park Center (BPC) by roughly 50% with an $8 million, 37,000-square-foot accelerator structure. The new accelerator space will be leased to existing tenants graduating from the incubator and other companies in the modest growth stage. Aurora, Colorado (PRWEB) December 12, 2011 In furtherance of its renewed commitment to support the growth of early-stage Colorado bioscience companies, especially those developing...
AURORA, Colo., Nov. 15, 2011 /PRNewswire/ -- In a strategic effort to refocus and strengthen its organization, the Fitzsimons Redevelopment Authority (FRA) has completed a regimen of planning to make adjustments in the direction, roles, responsibilities and allocation of resources going forward. The announcement is made by Denise Brown, FRA Interim Executive Director, who says, "Our first tactic in refocus involves augmenting our board of directors with four of the area's most well-known...
Dr. San Millan to Take Unique Approach in Applying Experience with Pro Teams and Elite Athletes to Treat At-Risk Patients AURORA, Colo., Aug. 25, 2011 /PRNewswire-USNewswire/ -- Sedentary and deconditioned individuals may soon benefit from the latest techniques used to improve performance in professional and elite athletes. In a move announced today by the University of Colorado School of Medicine, pioneering work undertaken by Inigo San Millan Ph.D., one of the world's foremost exercise...
WASHINGTON, Dec. 3, 2010 /PRNewswire-USNewswire/ -- The Global Down Syndrome Foundation, the Linda Crnic Institute for Down Syndrome, and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) will co-host the first "DOWN SYNDROME: National Conference on Patient Registries, Research Databases, and Biobanks" on December 2-3,2010 in Rockville, Maryland. The conference aims to address the lack of a national Down syndrome medical registry and biobank by...
DENVER, May 19 /PRNewswire/ -- Flanked by more than 100 leaders from business, healthcare and city and state government, Corporex officials broke ground on Fitzsimons Village, an $80 million hotel office complex in the Fitzsimons Life Sciences District in Aurora, Colo. Fitzsimons Village is the first new, mixed-use development that will bring needed amenities to the rapidly growing Fitzsimons Life Sciences District east of Denver. Phase one of the project includes a six-story, class A,...
AURORA, Colo., March 18 /PRNewswire/ -- Pharmatech Oncology has been selected by the Fitzsimons Redevelopment Authority to be a preferred vendor to the Colorado Science + Technology Park at Fitzsimons. The Technology Park is home to 25 pharmaceutical and biotechnology companies. The majority of the companies are in the research stage with a select number of companies expanding their research on commercial products. Pharmatech Oncology was chosen as a preferred vendor for its Contract...
AURORA, Colo., Sept. 3 /PRNewswire/ -- Developer Forest City Science + Technology Group broke ground today at a noon event at the Colorado Science + Technology Park at Fitzsimons, a 184-acre business park dedicated to life science focused companies, by demolishing the old Fitzsimons smokestack to make way for new, state-of-the-art scientific facilities. Plans call for Forest City's first life science building that will accommodate the growth of the region's existing life science industry as...
